CDC Guidance
DOH Guidance
DOHMH Guidance
NJ DOH Guidance
CMS Guidance
| Item | Date Updated |
|---|---|
| Emergency Medical Treatment and Labor Act (EMTALA) Requirements and Implications Related to COVID-19: Addresses screening obligations and stabilization, transfers, and recipient hospital obligations. | 3/30/2020 |
| CMS Announces Actions to Address Spread of Coronavirus | 3/4/2020 |
| Guidance for Infection Control and Prevention of COVID-19 in Hospitals, Psychiatric Hospitals, and Critical Access Hospitals | 3/30/2020 |
| Guidance for Infection Control and Prevention of COVID-19 in Outpatient Settings | 3/30/2020 |
| Guidance for Infection Control and Prevention of COVID-19 in Intermediate Care Facilities for Individuals with Intellectual Disabilities and Psychiatric Residential Treatment Facilities | 3/30/2020 |
| Guidance for Infection Control and Prevention of COVID-19 in dialysis facilities | 3/30/2020 |
Additional Guidance
| Item | Date Updated |
|---|---|
| Guidance on Using CHEMPACK Assets (ASPR) | 4/2/2020 |
| COVID-19 Clinical Guidance For the Cardiovascular Care Team (American College of Cardiology) | 3/6/2020 |
| COVID-19 FAQs for Obstetrician-Gynecologists, Obstetrics (American College of Obstetricians and Gynecologists [ACOG]) | — |
| Perinatal Quality Collaborative Webinar: Guided Discussion on COVID-19 and Pregnancy (ACOG) | 3/30/2020 |
| NIH Database to Track Neurological Symptoms Associated with COVID-19 (NIH): announced a new database to collect information from clinicians about COVID-19-related neurological symptoms, complications, outcomes, and effects on preexisting neurological conditions. Researchers and clinicians can request access to the database via the NeuroCOVID website. | 1/26/2021 |
| Planning Considerations for Monoclonal Antibody Administration (ASPR): describes monoclonal antibody therapy for COVID-19 patients and highlights considerations for providers and for planning and allocation. | 9/1/2021 |
| Post-Acute Sequelae of SARS-CoV-2 Infection (ASPR TRACIE): includes a perspective from NYC Health + Hospitals/Bellevue on ongoing symptoms, COVID-19’s effects on neurological systems, delirium and coma, and systemic pulmonary long-term symptoms. | 3/10/2021 |